Your browser doesn't support javascript.
loading
The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?
Goldsberry, Whitney N; Summerlin, Sarah S; Guyton, Allison; Caddell, Brittani; Huh, Warner K; Kim, Kenneth H; Liang, Margaret I.
Afiliação
  • Goldsberry WN; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Summerlin SS; School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Guyton A; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Caddell B; Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Huh WK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Kim KH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Liang MI; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America. Electronic address: mliang@uabmc.edu.
Gynecol Oncol ; 160(3): 800-804, 2021 03.
Article em En | MEDLINE | ID: mdl-33414026
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Gastos em Saúde / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Gastos em Saúde / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos